Literature DB >> 22053578

Osteolytic skull metastasis with dural involvement from a papillary thyroid carcinoma.

Karlo Houra1, Majda Vucić, Hrvoje Cupić, Damir Kovac, Vatroslav Cerina.   

Abstract

Skull metastatic tumors are relatively rare medical entities and originate most often from the lungs, breast or prostate. We report a case of a 76-year-old woman who presented with a bulging, well-circumscribed mass on the right side of the forehead. Neuroimaging of the cranium detected an osteolytic lesion measuring 7 cm in the largest diameter while propagating outwards and intracranially. A thorough medical history revealed that patient had undergone surgery for invasive breast ductal carcinoma and also for a well-differentiated thyroid carcinoma 13 years ago. Considering patients medical history metastatic breast carcinoma was suspected. After a frontal craniotomy the tumour tissue was totally resected. Histological examination revealed metastatic papillary carcinoma characterized by ground-glass nuclei with intranuclear pseudo inclusion and nuclear grooves. We report clinical and neuroradiological features of this uncommon lesion and discussed the differential diagnosis of skull osteolytic lesion together with the treatment management.

Entities:  

Mesh:

Year:  2011        PMID: 22053578

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  3 in total

1.  Osteolytic Skull Lesions-Our Experience.

Authors:  B V Sandeep; Manpreet Singh Banga; Suniti Kumar Saha; Kaushik Roy
Journal:  J Neurosci Rural Pract       Date:  2017 Jul-Sep

2.  Calvarium and dura mater as delayed sites of distant metastasis from papillary thyroid carcinoma.

Authors:  Khalid Hussain Al-Qahtani; Mutahir A Tunio; Mushabbab Al Asiri; Hanadi Fatani; Yasser Bayoumi
Journal:  Int Med Case Rep J       Date:  2015-10-16

Review 3.  Skull Metastasis Extending to the Superior Sagittal Sinus: An Unfamiliar Presentation of Papillary Thyroid Carcinoma.

Authors:  Abu Baker Sheikh; Aisha Akhtar; Usman Tariq; Abdul Ahad E Sheikh; Fasih Sami Siddiqui; Marvi M Bukhari
Journal:  Cureus       Date:  2018-06-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.